Stay updated with breaking news from Patrick Van Berkel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LAUSANNE, Switzerland, April 03, 2024 -- ADC Therapeutics SA today announced that the Company will host a virtual Research Investor Event on Tuesday, April 9, 2024, from 4:00 to 5:30 p.m. EDT. The...
/PRNewswire/ -- IntoCell today announced the signing of a Material Transfer Agreement (MTA) with option to license with ADC Therapeutics SA (NYSE: ADCT). Under...
– Freenome's comprehensive multiomics and multi-feature computational approach provides insights for therapy development and patient efficacySOUTH...
Company to host webcast today at 9:00 a.m. EST ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company improving the lives of those affected by cancer with its next-generation,